Those who are diagnosed with cancer face a hard decision: Treatment or not? People respond to treatment differently. Doctors have backlogs of data that show how different patients responded to different treatments, but they are unanalyzed, and analyzing them would take years. Enter Reverse The Odds, a mobile game that shows players slides from a cancer patient and asks the player something like “was there blue on the slide?” The slides are pictures of proteins—biomarkers that are key to showing how a patient responded to certain treatments. If lets say the biomarker is blue, and the patient responded well to treatment, then researchers might be able to draw the conclusion that patients with similar biomarkers should opt for treatment. The task is easy but requires a human’s eye and intellect, a computer cannot analyze the raw data. Reverse The Odds is rudimentary, but that’s the point—to breakdown these massive data sets into pieces that anyone can understand, and help analyze. Hopefully making one of life’s hardest decisions easier.
Help cancer patients by playing a mobile game
More of Today's Solutions
How Paraguay cut its poverty rate from over 50 to 16 percent in two decades
BY THE OPTIMIST DAILY EDITORIAL TEAM In 2005, more than half of Paraguay’s population lived in poverty. By 2025, that share had fallen to ...
Read MorePro parenting tips to spark your children’s life-long love for the grea...
BY THE OPTIMIST DAILY EDITORIAL TEAM In today's digital world, the pull of screens can be difficult to overcome, particularly for kids. However, the ...
Read MoreRainforest nations join forces to protect biodiversity
Late last month, major rainforest nations gathered in Brazzaville, Republic of Congo, to address the rising problem of deforestation and safeguard the invaluable biodiversity ...
Read MoreInvestigating when our bodies change the fastest and why it matters
BY THE OPTIMIST DAILY EDITORIAL TEAM Aging might seem like a slow, steady march, but science suggests otherwise. If you’ve ever looked in the ...
Read More
